Robert Blazej
InvestorPartner at Mission Biocapital · Partner at Mission Bay Capital · Board director at Telo Therapeutics, Inc.
San Francisco
Writes $500K checks
Find your path to Robert
427 people in our graph share verified history with Robert — schools, employers, funds. One of them is your warm intro.
Paul VeradittakitunlockedRobert: together at University of California, Berkeley (2001–2005)
×10Robert: together at University of California, Berkeley
Robert: together at Mission Bay Capital
About
Robert Blazej, a UCSF/UC Berkeley bioengineer PhD who co‑founded Allopartis and led its Novozymes integration, has daily exposure to early scientific founders through dual partner/director roles in a life‑science incubator.
Contact· published on Robert's own website
Invests in
AgTechBiotechFoodTechHealthtechMedical DevicesNew Materials
Board director at Telo Therapeutics, Inc.
Intro paths
→
In turn, Robert can intro founders to Telo Therapeutics, Inc.'s investors below.
Telo Therapeutics, Inc.'s investors · 1
Co-founders at Telo Therapeutics, Inc.
RB
Rob BellFounder
RB
Robert Bell Ph.D.CEO & Co-Founder
Experience
- ALLIn BioBoard Membercurrent2024 — presentSan Francisco Bay Area
- Nitrase TherapeuticsBoard Observercurrent2024 — presentSan Francisco Bay Area
- Interdict BioBoard Observercurrent2022 — presentSan Francisco Bay Area
- Telo Therapeutics, Inc.Board Membercurrent2021 — presentSan Francisco Bay Area
- Dren Bio, Inc.Board Observercurrent2020 — presentSan Francisco Bay Area
- MBC BiolabsVice President of Alliancescurrent2017 — present
- Mission Bay CapitalPartnercurrent2017 — presentSan Francisco CA
- Mission BioCapitalPartnercurrent2017 — presentCambridge MA
- GraphWear Technologies Inc.Board Member2024 — 2025San Francisco Bay Area
- Photoswitch Biosciences, Inc.Board Member2018 — 2023
- NovozymesManager2013 — 2017San Francisco Bay Area
- Allopartis Biotechnologies, Inc.CEO & President2007 — 2013San Francisco Bay Area
Skills & more
Biotechnology13Molecular Biology10Life Sciences4Biochemistry8PCR3Assay Development3Science5R&D1Venture Capital2Protein Chemistry5Lifesciences6Microfluidics2
+7 more
Biomedical EngineeringProject ManagementGenomicsMicrofabricationCell CulturePolymerase Chain Reaction (PCR)Research and Development (R&D)From Robert's professional profile.
Deals · 1
Telo Therapeutics, Inc.Board seat
via Mission Biocapital · filed Jun 2022 · $10.2M raise
Attribution from SEC filings, press coverage, and firm rosters.
Colleagues at Mission Biocapital
Cassidy Blundell
Partner at Mission Biocapital
Chaya Patel
Principal at Mission Biocapital
Chris Carlin
Chief Operations Officer and Chief Compliance Officer at Mission Biocapital
Clay Rowland
Investment Associate at Mission Biocapital
Douglas Crawford
Managing General Partner at Mission Biocapital
Jennifer Griffin
Partner at Mission Biocapital
Johannes Fruehauf
General Partner at Mission Biocapital
Josephine Brysting
Investment Analyst at Mission Biocapital
Frequently asked questions
- Who is Robert Blazej?
- Robert Blazej, a UCSF/UC Berkeley bioengineer PhD who co‑founded Allopartis and led its Novozymes integration, has daily exposure to early scientific founders through dual partner/director roles in a life‑science incubator.
- Where does Robert Blazej work?
- Robert Blazej is Partner at Mission Biocapital and Board director at Telo Therapeutics, Inc..
- What does Robert Blazej invest in?
- Robert Blazej invests in AgTech, Biotech, FoodTech, Healthtech, Medical Devices, New Materials.
- What check size does Robert Blazej write?
- Robert Blazej typically writes checks of $500K.
- What boards does Robert Blazej sit on?
- Robert Blazej holds tracked board seats at Telo Therapeutics, Inc..
- Where did Robert Blazej go to school?
- Robert Blazej studied at University of California, Berkeley (Doctor of Philosophy (Ph.D.), Bioengineering).
Same school
Also attended University of California, Berkeley2,000
Steve WozniakCo-founder of AppleAravind SrinivasCo-founder & CEO of Perplexity AIAli GhodsiCo-founder & CEO of DatabricksAbraham BachrachCo-founder & CTO of SkydioTrevor OelschigInvestment Team at General CatalystScott DavisInvestor at GV (Google Ventures)
+ 1,994 more
Shared employers
Also worked at Interdict Bio1
Also worked at Telo Therapeutics, Inc.1
Also worked at Novozymes18
Neha KumarVenture Partner at Floating PointKasim KutayCEO at Novo HoldingsPatricia CordeiroInvestment Partner LAC at Circulate CapitalThomas NagyOperational Partner at Astanor VenturesAmeena El-BibanyVenture Partner at Page One VenturesJack NielsenManaging Partner at Vivo Capital
+ 12 more